Results 101 to 110 of about 407,552 (296)

CA9‐Targeted PET Imaging for Noninvasive Discrimination of Clear Cell Renal Cell Carcinoma and Associated Tumor Biological Features

Advanced Science, EarlyView.
CA9‐targeted PET imaging could be a noninvasive approach to characterize clear cell renal cell carcinoma and associated tumor biology. PET uptake correlates with tumor CA9 expression and is linked to angiogenic activity, immune remodeling, and metabolic reprogramming.
Kailei Chen, Sixuan Cheng, Jian Shi, Ruijie Liu, Yilong Wu, Xin Zheng, Xinlun Song, Yunxuan Zhang, Lei Liu, Zhihao Wei, Qi Wang, Xinwei Li, Zirui Dong, Yuenan Liu, Hongmei Yang, Xiaoli Lan, Chunxia Qin, Dawei Jiang, Keshan Wang, Xiaoping Zhang   +19 more
wiley   +1 more source

Intravenous immunoglobulin compared with cyclophosphamide for proliferative lupus nephritis

, 1999
Among 14 randomised patients with proliferative lupus nephritis, monthly intravenous immunoglobulin maintained remission over 18 months, similar to standard intravenous cyclophosphamide treatment. Pulsed immunoglobulin may be a useful alternative therapy
Moutsopoulos, HM, Boki, KA, Ioannidis, JPA, Boletis, JN   +3 more
core   +1 more source

ADVERSE EFFECTS OF INTRAVENOUS IMMUNOGLOBULIN THERAPY IN PATIENTS WITH ANTIBODY DEFICIENCY

Iranian Journal of Allergy, Asthma and Immunology, 2003
Long-term intravenous immunoglobulin (IVIG) infusion is an effective treatment for children with humoral immunodeficiencies, already be complicated by systemic ad¬verse effects.
A. Aghamohammadi, A. Farhoudi, M. Moin, Zahra Pourpak, N. Rezaei, M. Nikzad, M. Movahedi, M. Gharagozlou, Lida Atarod, Akefeh Ahmadi Afshar, Nasrin Bazargan, K. Abolmaali Maryam Mahmoudi   +11 more
doaj  

Cerebral infarction following intravenous immunoglobulin therapy for Guillain-Barre syndrome

, 2001
Intravenous immunoglobulin (IvIg) therapy is used increasingly for different immune-mediated diseases, such as the Guillain-Barre syndryyome. We report the case of a 55-year-old man who developed a cerebral infarction 2 days after completion of treatment
Özmenoǧlu, Mehmet, BOZ, CAVİT, VELİOĞLU, SİBEL   +2 more
core   +1 more source

Targeted Degradation of Picornaviral 3C Protease via PROTACs Confers High Barrier to Viral Resistance and Broad‐Spectrum Antiviral Activity

Advanced Science, EarlyView.
This study reports D34 as the first PROTAC degrader that targets the 3C protease of picornaviruses. D34 effectively degrades EV71 3C protease via the ubiquitin‐proteasome pathway. More importantly, D34 exhibits a high resistance barrier and shows broad‐spectrum antiviral activity against multiple picornaviruses, highlighting its potential as a novel ...
Weilong Deng, Junyu Chen, Yingyue Pang, Yuanyuan Zhang, Siqian Chen, Guoliang You, Xiaoman Tian, Zhongxin Xu, Jing Wang, Luqing Shang   +9 more
wiley   +1 more source

Engineering Ultrastable Intrinsic Radicals: Graphene Quantum Dots With NIR‐II Emission for Dynamic Deep‐Tissue Bioimaging

Advanced Science, EarlyView.
Stable radicals are attractive for photonic and quantum information technologies but are often limited by instability. We stabilize intrinsic radicals in graphene quantum dots via 2D polymerization of perylene derivatives, where bilayer defect confinement suppresses quenching (100–500 K).
Qin Xu, Yijie Hou, Bingzhe Wang, Tesen Zhang, Yupeng Liu, Shuaiqi Li, Maohua Chen, Guichuan Xing, Dongbo Guo, Songnan Qu   +9 more
wiley   +1 more source

Aseptic Meningitis Associateded with Intravenous Immunoglobulin

, 2014
Aseptic meningitis can be an adverse drug reaction to intravenous immunoglobulin. We describe a previously healthy 4-yearold boy, admitted for idiopathic thrombocytopaenic purpura. He received two infusions of intravenous immunoglobulin.
Lito, D, Girbal, I, Francisco, T, Cunha, F   +3 more
core  

Engineered Xenogeneic Bone Scaffold with IL‐10 Nanodelivery System: Immunomodulation and BMSC Fate Programming for Skull Defect Repair

Advanced Science, EarlyView.
A multifunctional regenerative composite is constructed by 3D‐printing thermosensitive PNIPAM hydrogel embedded with MPDA@IL‐10 nanoparticles and autologous BMSCs onto antigen‐depleted porcine bone matrix for beagle critical‐sized skull defect reconstruction.
Weihao Lv, Lei Zhang, Fei Fei, Zhibin Wu, Xiuquan Wu, Ya‐nan Dou, Yihao Fu, Hao Chang, Yujie Qiang, Huaxia Xie, Ni An, Leiying Chen, Hongchen Zhang, Min‐Wen Zheng, Hongqing Chen, Xia Li, Zhou Fei   +16 more
wiley   +1 more source

Intravenous immunoglobulin treatment [INTRAVENOZ IMMUNOGLOBULIN TEDAVISI]

, 1995
The use of intravenous immunoglobulin (IVIG) treatment has been progressed during last fifty years. The indications of IVIG treatment are various. Several reports have suggested that IVIG treatment was effective in the treatment of different diseases. In
Turkay C., Canturk Z., Gultekin F.
core   +1 more source

Intravenous immunoglobulin therapy for severe Clostridium difficile colitis

, 1997
Background—Many individuals have serum antibodies against Clostridium difficile toxins. Those with an impaired antitoxin response may be susceptible to recurrent, prolonged, or severe C difficile diarrhoea and colitis.Aims—To examine whether treatment ...
J T LaMont, M Warny, I Castagliuolo, S Keates, J Salcedo, C Pothoulakis, C P Kelly   +6 more
core   +1 more source